VRTX
Vertex Pharmaceuticals Inc
Price:  
500.19 
USD
Volume:  
1,667,483.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex Fair Value

-104.40 %
Upside

What is the fair value of Vertex?

As of 2025-05-06, the Fair Value of Vertex Pharmaceuticals Inc (VRTX) is -22.00 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 500.19 USD, the upside of Vertex Pharmaceuticals Inc is -104.40%.

Is Vertex a good investment?

With the market price of 500.19 USD and our fair value calculation, Vertex Pharmaceuticals Inc (VRTX) is not a good investment. Investing in Vertex stocks now will result in a potential loss of 104.40%.

Note: valuation result may not be accurate due to the company's negative EPS.

500.19 USD
Stock Price
-22.00 USD
Fair Price
FAIR VALUE CALCULATION

Vertex Fair Value

Peter Lynch's formula is:

Vertex Fair Value
= Earnings Growth Rate x TTM EPS
Vertex Fair Value
= 10.56 x -2.08
Vertex Fair Value
= -22.00

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income 2,711.60 2,342.10 3,322.00 3,619.60 -535.60 2,291.94
YoY growth 130.42% -13.63% 41.84% 8.96% -114.80% 10.56%

Vertex Fair Value - Key Data

Market Cap (mil) 128,588.84
P/E
Forward P/E 453.73x
EPS -2.08
Avg earnings growth rate 10.56%
TTM earnings -535.60